“The existing condition has exposed some structural weaknesses in the EU’s medicines source chain and a higher dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides mentioned. She proposed that offer chain troubles be tackled in an EU pharmaceutical tactic predicted to get released by the top with th